Trametinib

Basic Information

Item Value
DrugBank ID DB08911
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 34

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 choroideremia KG + DL
2 non-cutaneous melanoma KG + DL
3 epithelioid cell melanoma KG + DL
4 eyelid melanoma KG + DL
5 scrotum melanoma KG + DL
6 CDK4 linked melanoma KG + DL
7 lentigo maligna melanoma KG + DL
8 acral lentiginous melanoma (disease) KG + DL
9 balloon cell malignant melanoma KG + DL
10 superficial spreading melanoma KG + DL
11 malignant melanoma of the mucosa KG + DL
12 nodular malignant melanoma KG + DL
13 amelanotic skin melanoma KG + DL
14 choroidal dystrophy, central areolar KG + DL
15 intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency KG + DL
16 bilateral parasagittal parieto-occipital polymicrogyria KG + DL
17 amyotrophic lateral sclerosis KG + DL
18 anus leiomyosarcoma KG + DL
19 uterine corpus epithelioid leiomyosarcoma KG + DL
20 uterine corpus myxoid leiomyosarcoma KG + DL
21 borderline ovarian serous tumor KG + DL
22 ovarian mucinous cystadenofibroma KG + DL
23 retroperitoneal sarcoma KG + DL
24 rete ovarii cystadenoma KG + DL
25 small intestinal sarcoma KG + DL
26 Mills syndrome KG + DL
27 ovarian benign neoplasm KG + DL
28 ovarian papillary cystadenoma KG + DL
29 malignant ovarian Brenner tumor KG + DL
30 serous neoplasm KG + DL
31 mucinous ovarian cystadenoma KG + DL
32 leiomyosarcoma KG + DL
33 ovarian surface papilloma KG + DL
34 amyotrophic lateral sclerosis, susceptibility to KG + DL

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). This report is for research purposes only and does not constitute medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.